Form 4: Amprius Technologies Executive Exercises Stock Options, Acquires Shares
SEC Form 4 Filing
Jonathan Bornstein, President of Amprius Lab, exercised stock options to acquire 1,007,867 shares of Amprius Technologies common stock at $0.05 per share.
Summary
- On April 12, 2024, Jonathan Bornstein, President of Amprius Lab, exercised stock options to acquire 1,007,867 shares of Amprius Technologies, Inc. common stock.
- The exercise price was $0.05 per share.
- Following the transaction, Bornstein directly owns 1,566,797 shares of Amprius Technologies common stock, which includes 558,930 restricted stock units.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction. The exercise of options can be seen as a positive signal, but it's also part of executive compensation.
Positives
- Executive's exercise of stock options demonstrates confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 09/14/2022 | Date stock options were exercisable |
| 04/12/2024 | Date of stock option exercise and share acquisition |
| 04/15/2024 | Date of Form 4 filing |
| 03/15/2027 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.